Ventyx Biosciences Inc (NASDAQ:VTYX) shares, rose in value on Wednesday, June 18, with the stock price up by 7.73% to the previous day’s close as strong demand from buyers drove the stock to $2.37.
Actively observing the price movement in the last trading, the stock closed the session at $2.20, falling within a range of $2.18 and $2.42. The value of beta (5-year monthly) was 0.85. Referring to stock’s 52-week performance, its high was $3.39, and the low was $0.78. On the whole, VTYX has fluctuated by 63.45% over the past month.
With the market capitalization of Ventyx Biosciences Inc currently standing at about $168.65 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-08.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that VTYX’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of Hold while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of VTYX currently trading nearly 11.22% and 50.32% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 60.95, while the 7-day volatility ratio is showing 9.38% which for the 30-day chart, stands at 8.25%. Furthermore, Ventyx Biosciences Inc (VTYX)’s beta value is 0.86, and its average true range (ATR) is 0.21.
A comparison of Ventyx Biosciences Inc (VTYX) with its peers suggests the former has fared considerably weaker in the market. VTYX showed an intraday change of 7.73% in last session, and over the past year, it shrunk by -17.71%%.
Data on historical trading for Ventyx Biosciences Inc (NASDAQ:VTYX) indicates that the trading volumes over the past 10 days have averaged 2.35 and over the past 3 months, they’ve averaged 1.49 million. According to company’s latest data on outstanding shares, there are 71.16 million shares outstanding.
Nearly 11.38% of Ventyx Biosciences Inc’s shares belong to company insiders and institutional investors own 68.68% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 6.74 million shares as on 2025-05-30, resulting in a short ratio of 4.67. According to the data, the short interest in Ventyx Biosciences Inc (VTYX) stood at 1006.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 7.22 million. The stock has risen by 8.22% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the VTYX stock heading into the next quarter.
